Last week, a report published in The BMJ slammed European drug regulations for allowing biopharmaceuticals to reap "billions" in profits on new drugs for rare diseases, but failing to incentivize sufficient R&D into new cures and treatments. A leading patient advocacy group, however, says that while the regulations may be in need of reform, they have helped advance treatments for many debilitating and deadly rare diseases.
At the peak of Europe’s Covid-19 crisis, the SOS Mediterranee boat crowded with some 180 migrants plucked from the sea in distress, moved from port to port across Italy and Malta as it was refused permission to disembark. Unlike the voyages of expensive cruise ships, caught offshore in the crosshairs of the Covid-19 crisis, no one noticed.
More and more scientists believe that Covid-19 can be transmitted by an infected person's breath or speech, emitting tiny airborne virus particles that can travel meters. WHO now admits this can happen but is downplaying the risks.
